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Objective: Subintimal angioplasty (SIA) has been advocated to treat long segment lower extremity arterial occlusions, but
many question its value. We evaluated the role of SIA in a group of patients with severe lower extremity arterial occlusive
disease.
Methods: During a 2.5-year period, 39 patients with arterial occlusions (median length, 8 cm; range, 2 to 31 cm) were
treated on an intention-to-treat basis with SIA. Twenty-five patients had gangrene, five had rest pain, and nine had
disabling (<one block) claudication. There were 24 superficial femoral, two superficial-femoral–popliteal, four popliteal,
two popliteal-tibial, five tibial, and two external iliac artery lesions. With fluoroscopic guidance, via a prograde common
femoral artery puncture (n  29) or a contralateral common femoral artery puncture (n  9), a subintimal dissection
plane was created across the occlusion with a standard guidewire and catheter. The arterial lumen was reentered distal to
the occlusion, and the recanalized segment balloon was dilated. All patients were followed prospectively with arterial
duplex scan.
Results: SIA was technically successful in 34 of 39 patients (87%). All five failures were from an inability to reenter the
patent lumen distally. These five patients underwent successful bypasses that in no case were more distal than would have
been required before SIA. In the 34 technically successful SIAs, pain completely resolved (14/14) and areas of gangrene
(21/25) healed. The cumulative patency rate in patients who underwent successful SIA was 74%  10% at 12 months.
The mean increase in ankle-brachial index after SIA was 0.34 (range, 0.1 to 0.69). There were two distal embolic events,
successfully treated surgically (n 1) or with catheter-directed techniques (n 1). Three patients underwent subsequent
bypass, and the remaining five patients remain asymptomatic.
Conclusion: SIA is feasible and can be effective in some patients with lower extremity arterial occlusions and threatened
limbs. These results, plus SIA’s many advantages, support an increasing role for it in the treatment of lower extremity
arterial occlusive disease. (J Vasc Surg 2003;37:386-91.)
Subintimal angioplasty for the treatment of occluded
femoropopliteal arteries was first described by Bolia, Bren-
nan, and Bell1 in 1989. The technique was developed in
Leicester, United Kingdom, in 1987 when, in the course of
treatment of a 15-cm popliteal occlusion, a subintimal
channel was accidentally created, balloon dilated, and rec-
ognized as such.2 The subsequent angioplasty remained
patent for more than 9 years. Experience from a small
number of centers in Europe has shown promising results
with this technique, and its applications have been ex-
panded to include crural and iliac arteries.3-17 Despite this
positive experience, the technique has not gained wide-
spread acceptance, and no such reports have been found in
the North American literature. It has been speculated that
this may be because of a steep learning curve or skepticism
regarding the procedure.5 We therefore evaluated the role
of subintimal angioplasty in a group of patients with severe
lower extremity ischemia.
METHODS
Thirty-nine patients underwent an attempt at subinti-
mal angioplasty between July 1999 and January 2002.
Patients with anatomically favorable lesions or severe med-
ical comorbidities were selected for subintimal angioplasty.
Anatomically favorable lesions were those in which a suit-
able length of relatively normal artery both proximal and
distal to the occluded segment permitted the creation of
the subintimal dissection plane and reentry into the native
lumen without potentially compromising major branch
vessels during the procedure or reducing future bypass
options.
Thirty procedures were performed in the operating
room (77%) and nine in the angiography suite (23%).
Thirty-four procedures were performed with local anesthe-
sia. In cases in which a foot or lower leg lesion necessitated
debridement (n  5), regional or general anesthesia was
used.
Procedures were performed with either an ipsilateral
antegrade common femoral artery (CFA) puncture (n 
29) or a contralateral CFA puncture (n  9). In the nine
cases where a contralateral puncture was used, subintimal
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angioplasty was performed with a long 6F sheath (Cordis,
Warren, NJ) placed over the aortic bifurcation. In one case,
bilateral retrograde CFA punctures were used to recanalize
an occluded external iliac artery. After arterial puncture and
sheath placement, patients were systemically heparinized.
An angled 0.035-in Terumo Glidewire (Meditech, Natick,
Mass) and a supporting 5F KMP catheter (Cook, Bloom-
ington, Ind) were used to create a subintimal dissection
plane above the level of the occlusion. The wire then was
advanced, and a loop was naturally formed at the tip of the
guidewire. The loop and catheter were advanced through
the subintimal plane until the occlusion was passed. A loss
of resistance was often encountered as the wire reentered
the true lumen of the native artery distal to the occlusion.
Recanalization was confirmed with advancing the catheter
over the guidewire beyond the point of reentry and per-
forming an angiogram. In cases where a contralateral punc-
ture was used, an angioplasty balloon was inflated proximal
to the lesion to stabilize the guidewire and allow the
necessary force to enter and traverse the subintimal plane
(Fig 1). The recanalized segment then was balloon dilated
at 8 to 10 atm with an appropriately sized angioplasty
balloon. Stents were placed only in the setting of iliac artery
subintimal angioplasty (n  2). No stents were used in the
area of any infrainguinal subintimal angioplasties. Patency,
adequacy of flow, and preservation of runoff were con-
firmed on completion angiography. Other significant ste-
notic arterial lesions that were identified outside the area of
subintimal angioplasty were treated concurrently at the
time of the procedure with adjunctive balloon angioplasty
or stent placement.
Patients were given clopidogrel bisulfate for 6 weeks
after the procedure, followed by aspirin indefinitely. Fol-
low-up consisted of routine office visits with pulse exami-
nation, pulse volume recordings with segmental limb pres-
sures, and serial surveillance color duplex ultrasound scan
evaluations at 3-month to 6-month intervals.
Technical success, outcome, complications, and long-
term patency were evaluated with the reporting standards
developed by the Joint Council of The Society for Vascular
Surgery and the North American Chapter of the Interna-
tional Society for Cardiovascular Surgery.18 Hemodynamic
patency was defined as prograde flow without hemodynam-
ically significant residual stenoses (30%) as shown on
color duplex scan examination or angiography. Symptom-
atic patency was defined as improvement in walking dis-
tance by at least one level, resolution of rest pain, healing of
ulcers, minor amputations or areas of gangrene, and, for the
purpose of this analysis, no need for bypass surgery. All
patency rates are primary patency rates.
RESULTS
The 22 men (56%) and 17 women (44%) ranged in age
from 46 to 89 years (median, 74 years). Many patients had
significant medical comorbidities, including hypertension
(n  20), chronic renal insufficiency (n  3), end-stage
renal disease (n  5), smoking (n  14), previous myocar-
dial infarction (n  16), arrhythmia (n  2), non–insulin
dependent diabetes (n  15), insulin-dependent diabetes
(n  7), and chronic obstructive pulmonary disease (n 
1). Two patients had undergone previous coronary bypass.
Two patients had a failed previous ipsilateral lower extrem-
ity bypass, and two patients had a failed previous ipsilateral
standard lower extremity balloon angioplasty.
Twenty-five patients (64%) had gangrene (category 5),
five (13%) had rest pain (category 4), and nine (23%) had
disabling (one block) claudication (category 3). There
were 24 superficial femoral artery (SFA), two SFA–popliteal
artery, five popliteal artery, two popliteal-tibial artery, four
tibial artery, and two external iliac artery lesions. The
median occlusion length for all patients was 8 cm (range, 2
to 31 cm). The median occlusion length for patients with
SFA occlusions was 8 cm (range, 4 to 20 cm). The average
runoff score for patients with SFA occlusions only was 5.18
Subintimal angioplasty was technically successful in 34
of 39 patients (87%). In each of the five unsuccessful cases,
the reason for failure was an inability to reenter the patent
lumen distally. All five of these patients underwent success-
ful bypass surgery, which in no case was more distal than
would have been required before the attempt at subintimal
angioplasty. The hemodynamic patency rates at 12 and 24
months for the entire group (intention-to-treat basis) were
64% and 51%, respectively (Fig 2, Table I). Symptomatic
patency rates were 68% and 61% at 12 and 24 months,
respectively (Fig 3, Table II). Limb salvage rates with
life-table analysis for the 30 patients with category 4 and 5
ischemia were 90%  7% at 12 months (Table III).
In the 34 technically successful subintimal angioplas-
ties, rest pain and claudication completely resolved (14/
14) and areas of gangrene healed (21/25). The cumulative
patency rate in patients who underwent successful subinti-
mal angioplasty was 74%  10% at 12 months. The mean
increase in ankle-brachial index after subintimal angioplasty
was 0.34 (range, 0.10 to 0.69). For the 34 technically
successful subintimal angioplasties, hemodynamic patency
rates at 12 and 24 months were 74% and 59%, respectively.
Symptomatic patency rates were 79% and 70% at 12 and 24
months, respectively. The hemodynamic patency rates for
the technically successful SFA angioplasties were 75% and
57% at 12 and 24 months, respectively.
Twelve adjunctive procedures were performed in 11 of
the 34 patients who underwent successful subintimal an-
gioplasty. These procedures consisted of iliac artery angio-
plasty and stenting (n 2), standard angioplasty of the SFA
proximal to the subintimal angioplasty (n  8), and stan-
dard angioplasty of the popliteal artery distal to the subin-
timal angioplasty (n  2). One additional patient had a
subclavian artery angioplasty for a symptomatic stenosis.
No periprocedural myocardial infarctions, strokes, in-
stances of renal failure, or pulmonary complications oc-
curred. One femoral puncture site pseudoaneurysm was
successfully treated with compression in the vascular labo-
ratory. There were two cases of distal embolization, both to
the tibioperoneal trunk. One case was successfully treated
with surgical thrombectomy, and the other with catheter-
directed suction thrombectomy. There were four major
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amputations, three below the knee and one transtarsal. All
were performed for gangrene with unresolved infection.
Two of these patients, both of whom had large areas of heel
gangrene and infection, had a patent SFA subintimal an-
gioplasty at the time of amputation. One of the remaining
two patients had a failed initial attempt at subintimal angio-
plasty, and the other had failure 3 months after the proce-
dure; both underwent bypass. Five patients had successful
toe amputations to treat preexisting areas of gangrene.
Eight late failures occurred at 1, 2, 3, 4, 4, 5, 11, and 16
months after the subintimal angioplasty. In all cases, ankle-
brachial indices returned to baseline. Five of these patients
remain asymptomatic. Three of these patients became
symptomatic and subsequently underwent successful elec-
tive bypass surgery. In two cases, the bypass was no more
distal than it would have been before the subintimal angio-
plasty. However, in one case, a bypass was performed to the
proximal anterior tibial artery rather than to the above-knee
Fig 1. Subintimal angioplasty performed via contralateral retrograde CFA puncture. 6F sheath (tip at arrow) is placed
over aortic bifurcation (A). Angioplasty balloon inflated proximal to occlusion to stabilize wire enables formation of
loop (arrow) and subintimal dissection (B, C, and D). Presubintimal and postsubintimal angioplasty (E and F).
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popliteal artery, as would have been performed before
attempt at subintimal angioplasty. Only one of the patients
with late failure had undergone an adjunctive angioplasty.
The failure in this case occurred with in the segment treated
with subintimal angioplasty.
Eight patients in this series (five with technical failures
and three with late failures) needed bypass. There were five
femoropopliteal bypasses (four with greater saphenous vein
[GSV], one with polytetrafluoroethylene), two femoral-
anterior tibial bypasses with GSV, and one popliteal-dorsa-
lis pedis bypass with GSV. The primary patency rate for
these bypasses was 88%, and the secondary patency rate was
100% over the study period.
DISCUSSION
Since the Leicester group’s initial report, the experi-
ence with subintimal angioplasty has expanded to include
more than a thousand patients and additional anatomic
segments, including tibial and iliac vessels.6,9-11 The initial
technical success rate of 87% and the 74%  10% 1-year
life-table patency rate in our series are comparable with the
early experience documented in other published re-
ports.5,16 We found no significant correlation in our series
between any of the various patient demographic or ana-
tomic factors, including occlusion length, and either tech-
nical success or long-term patency, perhaps in part because
of our relatively small sample size. Median occlusion
lengths for technical successes versus failures were 8 and 6
cm, respectively, and median occlusion lengths for both
patent and long term failures were 8 cm. We subjectively
noted that in patients where reentry was not possible that
there tended to be relatively dense, calcific disease through-
out the arterial tree.
One technical modification we have used is the over-
the-top 6F sheath with balloon stabilization of the guide-
wire for the performance of subintimal angioplasty. This
permits the performance of a complete diagnostic angio-
gram and subintimal angioplasty without a second punc-
ture. In addition, any incidentally encountered aortoiliac
disease can be concurrently treated. It also avoids the
complications associated with the somewhat more difficult
prograde puncture.
Fig 2. Life-table for hemodynamic patency. Dashed line indicates standard error of more than 10%. Details of analysis
are available in Table I (online only).
Fig 3. Life-table for symptomatic patency. Dashed line indicates standard error of more than 10%. Details of analysis
are available in Table II (online only).
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Some patients in our series had adjunctive procedures
to treat other nonocclusive lesions concurrently with sub-
intimal angioplasty. All these procedures were traditional
angioplasties. Ten of the 11 adjunctive procedures were
performed to maximize the inflow and outflow of the
treated segment and give the subintimal angioplasty the
greatest chance of long-term patency, just as would be
required in the setting of a bypass surgery. To date, we have
found no significant differences in the failure rate of pa-
tients who did or did not need an adjunctive procedure. If
anything, the need for these procedures indicates more
severe disease, which could increase the likelihood of both
early and late failures.
The subintimal dissection plane has a characteristic
resistance when entered, traversed, and exited. Perhaps a
more important indication that one is in the subintimal
plane is the formation of the wire into a “wide loop” as
described by Bolia and Bell.2 When this wide loop is
formed, the diameter of the loop at its distal end is larger
than that of the artery’s native lumen. To fully appreciate
this phenomenon, the wire must be imaged in a plane that
is perpendicular to the loop. Finally, the wire will frequently
take a course that seems to spiral around the lumen of the
artery. This is because the path of least resistance rarely lies
in the same longitudinal plane of the artery. Despite these
strong predictors of subintimal wire position, the exact path
of the wire cannot be controlled throughout the entire
occluded segment. Because the technique is not performed
with direct visualization, one must rely on the fluoroscopic
appearance of the wire and loop to confirm position in the
subintimal plane.
Subintimal recanalization through a retrograde popli-
teal approach has also been described.19-21 In this ap-
proach, a retrograde popliteal artery puncture is made with
ultrasound scan guidance and recanalization performed in a
distal to proximal direction. Yilmaz et al21 reported a 62%
patency rate at 1 year for 39 such subintimal recanaliza-
tions.
Another variation on the approach to subintimal angio-
plasty has also been described. Balas et al22 reported on
“open” subintimal angioplasty in cases where there is a
flush occlusion at the origin of the SFA. When a flush
occlusion is present, it may be difficult to initiate the
subintimal dissection plane. In addition, the origin of the
profunda femoral artery may be compromised either by the
dissection or the subsequent balloon angioplasty. This pro-
cedure involves a cutdown with exposure of the common,
superficial, and deep femoral arteries. The SFA is opened,
and a subintimal dissection plane created with direct visu-
alization. The dissection is then completed and the native
lumen reentered endoluminally with fluoroscopic guid-
ance. After balloon angioplasty, a formal endarterectomy of
the SFA is performed and the proximal origin of the dissec-
tion plane is tacked open with sutures. The artery is closed
with a patch. Such an approach may expand the applicabil-
ity of the technique but does make any subsequent inter-
vention more complex by virtue of the operative scarring.
Until the long-term durability of this approach is deter-
mined, a primary bypass procedure may be preferable.
In our series, two patients underwent subintimal angio-
plasty after a failed bypass. Both procedures were per-
formed for a threatened limb and were technically success-
ful and remain patent at 8 and 26 months later. This is
potentially one of the more attractive scenarios for the use
of subintimal angioplasty in that it can avoid the technical
difficulties associated with reoperative bypass surgery.
However, Walker et al23 have recently reported on 12
patients with failed infrainguinal bypasses and limb threat.
These patients underwent an attempt at subintimal angio-
plasty of the occluded native vessels. Seven of the cases were
technically successful, but at a mean follow-up period of 4
weeks, only one of the previously occluded segments re-
mained patent. The long-term success in our series remains
to be seen.
In interpreting and comparing our results and those of
other authors with different therapies, it would be benefi-
cial to more precisely classify subintimal angioplasty by
procedural type. Subintimal angioplasty does not meet the
Joint Council criteria for a “reconstructive procedure,”
defined as “. . . an open procedure that is performed to
remove, replace, or bypass an obstructive or aneurysmal
lesion involving the vessel wall and restore pulsitile flow
beyond the involved segment.”18 We also believe that
subintimal angioplasty does not meet the Joint Council
criteria for a “restorative procedure,” defined as “. . . one in
which the obstructing element (often clot or plaque) is
removed or displaced from the lumen of an arterial or
venous segment, allowing flow through the lumen to be
restored to normal or near normal without direct recon-
struction.”18 This is because “restorative” procedures typ-
ically restore flow through the native lumen. Subintimal
angioplasty creates a new conduit for blood flow with a
potential channel within the artery while leaving the native
lumen obliterated. Perhaps the term “neorestorative”
could be used to define this procedure.
Our early results are comparable with those of the
Leicester group. We currently believe that subintimal an-
gioplasty will continue to have a role in the treatment of
lower extremity ischemia. It offers many advantages, in-
cluding reduced anesthesia requirements and a minimally
invasive approach, and may potentially reduce length of
stay and cost. When applied judiciously, bypass options can
be preserved. We do not, however, believe that the avail-
ability of this technique should be used as justification to
lower the threshold for the treatment of mild intermittent
claudication. Our follow-up to date is somewhat limited,
and the ultimate utility and applicability of this technique
will be determined by its long-term results.
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Table I, online only. Hemodymamic life-table patency















0 to 1 39 6 2 0.158 84.2% 5.36%
1 to 3 31 2 2 0.067 78.6% 6.53%
3 to 6 27 3 3 0.118 69.3% 7.39%
6 to 9 21 0 6 0.000 69.3% 8.38%
9 to 12 15 1 5 0.080 63.8% 9.91%
12 to 15 9 0 3 0.000 63.8% 12.80%
15 to 18 6 1 2 0.200 51.0% 14.58%
18 to 21 4 0 0 0.000 51.0% 17.86%
21 to 24 4 0 0 0.000 51.0% 17.86%
Total 13 23















0 to 1 39 6 2 0.158 84.2% 5.36%
1 to 3 31 1 2 0.033 81.4% 6.30%
3 to 6 28 1 3 0.038 78.3% 6.89%
6 to 9 24 0 6 0.000 78.3% 7.44%
9 to 12 18 2 5 0.129 68.2% 9.06%
12 to 15 11 1 3 0.105 61.0% 11.49%
15 to 18 7 0 2 0.000 61.0% 14.40%
18 to 21 5 0 0 0.000 61.0% 17.04%
21 to 24 5 0 0 0.000 61.0% 17.04%
Total 11 23















0 to 1 30 0 0 0.000 100.0% 0.00%
1 to 3 30 1 1 0.034 96.6% 3.25%
3 to 6 28 2 2 0.074 89.5% 5.49%
6 to 9 24 0 5 0.000 89.5% 5.93%
9 to 12 19 0 4 0.000 89.5% 6.66%
12 to 15 15 1 5 0.080 82.3% 8.94%
15 to 18 9 0 1 0.000 82.3% 11.54%
18 to 21 8 0 0 0.000 82.3% 12.24%
21 to 24 8 0 8 0.000 82.3% 12.24%
Total 4 26
